A major population proteomics study using UK Biobank patient samples backed by 14 pharma companies has launched today with ...

Through a series of position papers, the EFPIA representing brandname drugmakers, self-medication group organisation AESGP, ...

Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical ...

According to the paper by researchers at the University of Bath in the UK and Lund University in Sweden, the self-regulated ...

Bioanalysis is also used to monitor therapeutic responses by evaluating drug levels, biomarkers, and physiological changes ...

In conclusion, I see 2025 as a year in which the patient will still be centre-stage. But, in order for that to happen ...

Capricor Therapeutics has completed its US marketing application for deramiocel, a cell therapy the US biotech hopes will ...

This tiered approach allows investors to engage at the level they’re most comfortable with, sparking their interest with a ...

Although Boston, San Francisco, and San Diego are the top three life sciences markets in the US, they are burdened by an oversupply of lab buildings that offer lab space. There is an undersupply of ...

The UK's Poolbeg Pharma has disclosed that it is in talks over a possible takeover by Hookipa, an Austrian biotech that is listed on the Nasdaq.